Cascade Investment Advisors Inc. Has $2.52 Million Stake in Nutrien Ltd. (NYSE:NTR)

Cascade Investment Advisors Inc. lessened its position in Nutrien Ltd. (NYSE:NTRGet Rating) by 5.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 33,555 shares of the company’s stock after selling 1,813 shares during the period. Nutrien makes up about 1.5% of Cascade Investment Advisors Inc.’s investment portfolio, making the stock its 5th biggest holding. Cascade Investment Advisors Inc.’s holdings in Nutrien were worth $2,523,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Bank of New York Mellon Corp increased its stake in Nutrien by 38.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,306,045 shares of the company’s stock valued at $84,671,000 after buying an additional 361,614 shares during the last quarter. Albar Capital Ltd increased its stake in Nutrien by 404.5% in the 3rd quarter. Albar Capital Ltd now owns 252,748 shares of the company’s stock valued at $16,386,000 after buying an additional 202,647 shares during the last quarter. Oppenheimer & Co. Inc. increased its stake in Nutrien by 72.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 85,722 shares of the company’s stock valued at $6,446,000 after buying an additional 35,873 shares during the last quarter. Morgan Stanley increased its stake in Nutrien by 4.1% in the 3rd quarter. Morgan Stanley now owns 2,109,828 shares of the company’s stock valued at $136,780,000 after buying an additional 83,379 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its stake in Nutrien by 12.6% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 20,390 shares of the company’s stock valued at $1,534,000 after buying an additional 2,274 shares during the last quarter. 64.39% of the stock is owned by hedge funds and other institutional investors.

NTR traded up $3.54 on Friday, reaching $98.95. The company had a trading volume of 2,599,195 shares, compared to its average volume of 3,842,035. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.53 and a current ratio of 1.14. The stock has a market cap of $54.67 billion, a P/E ratio of 12.70, a P/E/G ratio of 0.75 and a beta of 0.87. Nutrien Ltd. has a fifty-two week low of $57.08 and a fifty-two week high of $117.25. The company’s fifty day moving average is $102.90 and its 200 day moving average is $83.10.

Nutrien (NYSE:NTRGet Rating) last posted its quarterly earnings data on Monday, May 2nd. The company reported $2.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.59 by $0.11. The firm had revenue of $7.66 billion during the quarter, compared to the consensus estimate of $7.77 billion. Nutrien had a net margin of 14.34% and a return on equity of 20.55%. On average, sell-side analysts expect that Nutrien Ltd. will post 16.12 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 14th. Shareholders of record on Thursday, March 31st were issued a $0.48 dividend. The ex-dividend date of this dividend was Wednesday, March 30th. This represents a $1.92 dividend on an annualized basis and a yield of 1.94%. This is an increase from Nutrien’s previous quarterly dividend of $0.46. Nutrien’s payout ratio is currently 24.65%.

NTR has been the topic of several recent research reports. Barclays lifted their price target on shares of Nutrien from $84.00 to $92.00 and gave the company an “overweight” rating in a research note on Friday, February 18th. Citigroup lifted their price target on shares of Nutrien from $89.00 to $126.00 and gave the company a “buy” rating in a research note on Tuesday, March 22nd. Royal Bank of Canada boosted their price objective on shares of Nutrien from $120.00 to $135.00 and gave the stock an “outperform” rating in a research note on Thursday, April 21st. TD Securities boosted their price objective on shares of Nutrien from $125.00 to $130.00 and gave the stock a “buy” rating in a research note on Wednesday, May 4th. Finally, Raymond James boosted their price objective on shares of Nutrien from $105.00 to $125.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 4th. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $102.20.

About Nutrien (Get Rating)

Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.

See Also

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRGet Rating).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.